BNTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioNTech SE

Watchlist Manager

Watchlist

Price: 111.24 USD -1.17% Market Closed

Market Cap: $28.1B

	BioNTech SE NASDAQ:BNTX	DE
H	Humana Inc XMUN:HUM	US
	Noble Corp (Cayman Island) NYSE:NE	US

Profitability Summary

BioNTech SE's profitability score is 31/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

84%

Declining Gross Margin

87% > 79%

Negative Operating Margin

-42%

Negative 3Y Average Operating Margin

-12%

Declining Operating Margin

64% > -42%

Negative Net Margin

-64%

Negative 3Y Average Net Margin

-16%

Declining Net Margin

48% > -64%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

29%

Declining Free Cash Flow Margin

95% > 17%

Negative ROE

-9%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-4%

Declining ROIC

49% > -10%

View All

Hide

Collapse

31 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.